Rosen Law Firm has filed a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertisers and charging for prescriptions prematurely. The lawsuit claims these actions misled investors and exposed the company to regulatory scrutiny and potential penalties, causing investor losses. Investors who purchased Hims securities between August 2025 and July 2026 may join the suit and seek compensation without upfront fees. The case is ongoing, and no class has been certified yet.
Hims & Hers Health, Inc. is under investigation following a lawsuit filed by the FTC and state authorities alleging the company misled consumers by charging for prescriptions immediately after intake forms and making subscription cancellations diffic...
The FDA issued warnings to telehealth companies and compounding pharmacies about the use of unapproved compounded weight-loss drugs, including versions of semaglutide, tirzepatide, and retatrutide. Hims & Hers Health shares fell 3.2% following the an...
The Federal Trade Commission, along with California and Utah consumer protection agencies, sued Hims & Hers Health, Inc. for allegedly charging customers immediately after intake forms without clear disclosure and making subscription cancellations di...
